AP NEWS

Global Head & Neck Cancer Market and Competitive Landscape 2014-2018 & Prevalence Forecast to 2023 - ResearchAndMarkets.com

October 8, 2018

DUBLIN--(BUSINESS WIRE)--Oct 8, 2018--The “Global Head & Neck Cancer Market and Competitive Landscape - 2018” report has been added to ResearchAndMarkets.com’s offering.

Global Head & Neck Cancer Market and Competitive Landscape - 2018, provides comprehensive insights into Head & Neck Cancer pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Head & Neck Cancer market size and drug sales. This research also provides insights into Head & Neck Cancer epidemiology and late stage pipeline.

The research is classified into following sections - Head & Neck Cancer overview with definitions, symptoms, etiology, diagnosis, treatment options; Head & Neck Cancer pipeline insights covering late stage clinical trials pipeline; Head & Neck Cancer prevalence trends by countries; Head & Neck Cancer market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes G7 countries - US, Germany, France, Italy, Spain, UK, Japan.

Research Scope:

Head & Neck Cancer pipeline: Find out the drugs in clinical trials for Head & Neck Cancer by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company Head & Neck Cancer epidemiology: Find out the prevalence of Head & Neck Cancer by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2023 Head & Neck Cancer products: Identify key products marketed and prescribed for Head & Neck Cancer by brand name, by molecule, by company, by branded / generic, by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan Head & Neck Cancer market size: Find out the market size for Head & Neck Cancer drugs by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2014 Head & Neck Cancer drug sales: Find out the sales of Head & Neck Cancer drugs by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan, Global Head & Neck Cancer drugs sales forecast: Sales forecast for Head & Neck Cancer drugs to 2023 by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan Head & Neck Cancer market share analysis: Find out the market shares of Head & Neck Cancer drugs and outlook by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan

For more information about this report visit https://www.researchandmarkets.com/research/s9t8xk/global_head_and?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181008005639/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Oncology Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 10/08/2018 12:37 PM/DISC: 10/08/2018 12:38 PM

http://www.businesswire.com/news/home/20181008005639/en

AP RADIO
Update hourly